Pharmaco ‐disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries

ConclusionsThere was marked variation between countries in the retail price of HFrEF GDMT. Despite higher prices in high-income countries, GDMT was more accessible and affordable than in low- and middle-income countries. Publicly funded drug programmes in lower income countries increased affordability but limited access to newer HFrEF GDMT classes. Pharmaco-disparities must be addressed to improve HFrEF outcomes globally.

Source: ESC Heart Failure - August 30, 2023 Category: Cardiology Authors: Tauben Averbuch, Meisam Esfahani, Rani Khatib, James Kayima, Juan Jaime Miranda, Rishi K. Wadhera, Faiez Zannad, Ambarish Pandey, Harriette G. C. Van Spall Tags: Original Article Source Type: research